Jury slaps J&J with $63M verdict in Motrin case; Pharma sales down 15% on Spanish cuts;

@FiercePharma: Pharma girds for battle against Medicaid-level rebates for 'dual eligibles.' Fought and won before, but this time? More | Follow @FiercePharma

@EricPFierce: Takeda and one of its contract manufacturers sanctioned by Japanese regulator. Plant ordered closed for 12 days. News | Follow @EricPFierce

@AlisonBFierce: 2012 marked the largest whooping cough outbreak in 50 years. A new vaccine-resistant strain may be to blame. Report | Follow @AlisonBFierce

> Johnson & Johnson ($JNJ) was hit with a $63 million jury verdict in a lawsuit over the Motrin painkiller, which was blamed for a young girl's case of Stevens-Johnson Syndrome. Report

> Almost all drugmakers operating in Spain say their sales there have fallen an average of 15% over the past two years because of government cost-cutting. Report

> Drugmakers vow to fight President Obama's latest calls for Medicaid-level rebates on drugs used by patients who are eligible for both Medicare and Medicaid. Report

> India's Dr. Reddy's Laboratories posted a larger-than-expected drop in quarterly profits as North American sales disappointed. Report

> Zydus Cadila won FDA approval for its version of the Takeda Pharmaceutical diabetes drug Actos. Report

Medical Device News

 @FierceMedDev: Special Report: R&D advances in cancer Dx. Special Report | Follow @FierceMedDev

 @MarkHFierce: Medtronic wins with new study that touts merit of DBS for early Parkinson's. More | Follow @MarkHFierce

 @DamianFierce: The medical device tax is particularly treacherous for small companies, Theragenics says. Article | Follow @DamianFierce

> Rigid FX cited for quality violations concerning orthopedic surgical device. Item

> Hospira back in FDA's sights over device manufacturing. Story

Biotech News

 @FierceBiotech: Sanofi rebuilds early-stage R&D strategy in thriving Boston/Cambridge hub. Story | Follow @FierceBiotech

@JohnCFierce: Gregoire exits Shire HGT one step ahead of new CEO's debut (any chance this is connected to new CEO selection?) Article | Follow @JohnCFierce

@RyanMFierce: Boehringer Ingelheim goes to Hungary for R&D software. Article | Follow @RyanMFierce

> Biotech startup scores $20M C round for OTC weight-loss product and diabetes med. Article

> Third Rock bankrolls cancer immunotherapy upstart with $47M A round. News

Pharma Manufacturing News

> Takeda, CMO hit with sanctions by Japanese regulator. More

> Baxter beefing up cytotoxic manufacturing. Story

> Sanofi again turns to Waterford plant for production solution. Report

> Hospira moves forward with two plants in India. Article

Vaccines News

> Study: Untreated depression decreased effectiveness of shingles vaccine. More

> New whooping cough strain may resist vaccine. Story

> PharmaJet needle-free injector nabs WHO nod. Article

> EMA: Intercell can market Ixiaro in EU. More

> GSK flu vaccine additive under the microscope. Report

And Finally... The use of emergency contraception by American women has more than doubled to 11% from 4% in 2002. Report (sub. req.)

Suggested Articles

Cannes Lions Health kicks off Monday, and attendees are looking for some breakouts—leading-edge tech, creativity and inspiration, for instance.

Bluebird has priced gene therapy Zynteglo at €1.575 million in Europe and promised a U.S. price in “reasonably close” range.

Generic pain drug maker Lannett is closing its plant in Wyoming and laying off the remaining 80 employees.